Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Asset Resilience Ratio

Latest as of June 2026: 0.02%

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd asset resilience ratio. Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has an Asset Resilience Ratio of 0.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Tonghua Golden-Horse Pharmaceutical Indu fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.04 Million

≈ $151.46K USD Cash + Short-term Investments

Total Assets

CN¥4.71 Billion

≈ $688.58 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (2002–2025)

Asset resilience ratio of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 2002 to 2025. This chart shows how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's Asset Resilience Ratio has changed over time. Read 000766 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Tonghua Golden-Horse Pharmaceutical Indu balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.04 Million	0.02%
Total Liquid Assets	CN¥1.04 Million	0.02%

Asset Resilience Insights

Limited Liquidity: Tonghua Golden-Horse Pharmaceutical Industry Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Asset Resilience Ratio by Year (2002–2025)

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	CN¥1.07 Million ≈ $157.08K	CN¥4.48 Billion ≈ $655.09 Million	0.00pp
2024-12-31	0.02%	CN¥1.09 Million ≈ $159.29K	CN¥4.48 Billion ≈ $656.09 Million	+0.00pp
2023-12-31	0.02%	CN¥1.05 Million ≈ $153.44K	CN¥4.52 Billion ≈ $661.31 Million	+0.02pp
2022-12-31	0.00%	CN¥128.39K ≈ $18.79K	CN¥4.69 Billion ≈ $685.58 Million	0.00pp
2021-12-31	0.00%	CN¥180.33K ≈ $26.39K	CN¥4.64 Billion ≈ $679.09 Million	-1.86pp
2020-12-31	1.86%	CN¥92.63 Million ≈ $13.55 Million	CN¥4.98 Billion ≈ $728.92 Million	+1.71pp
2019-12-31	0.14%	CN¥6.80 Million ≈ $995.05K	CN¥4.70 Billion ≈ $687.47 Million	-0.15pp
2018-12-31	0.30%	CN¥17.80 Million ≈ $2.60 Million	CN¥5.96 Billion ≈ $871.88 Million	-4.29pp
2017-12-31	4.59%	CN¥262.80 Million ≈ $38.46 Million	CN¥5.73 Billion ≈ $838.02 Million	-0.34pp
2016-12-31	4.93%	CN¥261.50 Million ≈ $38.27 Million	CN¥5.30 Billion ≈ $776.07 Million	+4.55pp
2015-12-31	0.38%	CN¥15.90 Million ≈ $2.33 Million	CN¥4.16 Billion ≈ $608.11 Million	--
2014-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.29 Billion ≈ $188.12 Million	--
2003-12-31	0.01%	CN¥80.00K ≈ $11.71K	CN¥1.44 Billion ≈ $210.85 Million	-0.01pp
2002-12-31	0.01%	CN¥200.00K ≈ $29.27K	CN¥1.53 Billion ≈ $224.00 Million	--

pp = percentage points

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.95 Billion

CN¥13.33 Billion CNY

Market Cap Rank

#6000 Global

#1070 in China

Share Price

CN¥13.79

Change (1 day)

-3.57%

52-Week Range

CN¥13.79 - CN¥29.50

All Time High

CN¥29.50